✦ LIBER ✦

Phase I Study of the BLP25 (MUC1 Peptide) Liposomal Vaccine for Active Specific Immunotherapy in Stage IIIB/IV Non–Small-Cell Lung Cancer

✍ Scribed by Martin Palmer; Joanne Parker; Shanu Modi; Charlie Butts; Mike Smylie; Allison Meikle; Mairead Kehoe; Grant MacLean; Mike Longenecker

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Commentary on “Phase I Study of the BLP2

✍ Kathy Schiffman; Mary L. Disis 📂 Article 📅 2001 🏛 CIG Media Group, LP. 🌐 English ⚖ 53 KB

O-083 A multicenter phase IIB randomized

✍ Butts, C. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 130 KB

INSPIRE: A phase III study of the BLP25

✍ Yi-Long Wu; Keunchil Park; Ross A Soo; Yan Sun; Karin Tyroller; David Wages; Guy 📂 Article 📅 2011 🏛 BioMed Central 🌐 English ⚖ 259 KB

Phase I–II study of gemcitabine and pacl

✍ Iaffaioli, Rosario Vincenzo; Tortoriello, Anna; Gravina, Adriano; Facchini, Gaet 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 77 KB

A phase I study of paclitaxel in combina

✍ Ukena, Dieter; Berg, Monika; Leutz, Michaela; Zell, Lothar; Schlimmer, Paul; Syb 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 72 KB

Phase I study of paclitaxel (Taxol®) plu

✍ Breton, J.L.; Westeel, V.; Jacoulet, P.; Mercier, M.; Chazard, M.; Depierre, A. 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 75 KB